Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Matter

Showing results (311-320 of 324) with videos related to

Pageof 33
Sort By:
European Heart Journal|November 21, 2017
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromesRoland Klingenberg, Soheila Aghlmandi, Christoph Liebetrau, et al.
Physics in Medicine and Biology|September 18, 2024
First clinical implementation of a highly efficient daily online adapted proton therapy (DAPT) workflowF Albertini, K Czerska, M Vazquez, et al.
Cardiovascular Research|June 16, 2022
Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational studySamuele Ambrosini, Fabrizio Montecucco, Detmar Kolijn, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerationsJ Wouter Jukema, Maddalena Lettino, Petr Widimský, et al.
JAMA|April 3, 2022
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical TrialLorenz Räber, Yasushi Ueki, Tatsuhiko Otsuka, et al.
Journal of the American College of Cardiology|September 1, 2022
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial InfarctionBarbara E Stähli, Roland Klingenberg, Dik Heg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 4, 2018
Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injuryAlexander Akhmedov, Nicole R Bonetti, Martin F Reiner, et al.
European Heart Journal|April 30, 2016
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterolReijo Laaksonen, Kim Ekroos, Marko Sysi-Aho, et al.
European Heart Journal|March 8, 2026
Silent plaque ruptures in non-obstructive lesions of non-infarct-related arteries: a multimodality, serial intracoronary imaging studyRyota Kakizaki, Flavio G Biccirè, Sylvain Losdat, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registriesNicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
Pageof 33

Showing results (311-320 of 324) with videos related to

Sort By:
Pageof 33
European Heart Journal|November 21, 2017
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromesRoland Klingenberg, Soheila Aghlmandi, Christoph Liebetrau, et al.
Physics in Medicine and Biology|September 18, 2024
First clinical implementation of a highly efficient daily online adapted proton therapy (DAPT) workflowF Albertini, K Czerska, M Vazquez, et al.
Cardiovascular Research|June 16, 2022
Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational studySamuele Ambrosini, Fabrizio Montecucco, Detmar Kolijn, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerationsJ Wouter Jukema, Maddalena Lettino, Petr Widimský, et al.
JAMA|April 3, 2022
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical TrialLorenz Räber, Yasushi Ueki, Tatsuhiko Otsuka, et al.
Journal of the American College of Cardiology|September 1, 2022
Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial InfarctionBarbara E Stähli, Roland Klingenberg, Dik Heg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 4, 2018
Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injuryAlexander Akhmedov, Nicole R Bonetti, Martin F Reiner, et al.
European Heart Journal|April 30, 2016
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterolReijo Laaksonen, Kim Ekroos, Marko Sysi-Aho, et al.
European Heart Journal|March 8, 2026
Silent plaque ruptures in non-obstructive lesions of non-infarct-related arteries: a multimodality, serial intracoronary imaging studyRyota Kakizaki, Flavio G Biccirè, Sylvain Losdat, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registriesNicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
Pageof 33